Expression of Interleukin-12 is Increased in Psoriatic Skin
Authors:
- Lasse R. BraathenLBLasse R. Braathen
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 111 (6) , 1053-1057
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Transition from symptomless to lesional psoriatic skinClinical and Experimental Dermatology, 1996
- Constitutive Expression of Both Subunits of Interleukin-12 in Human KeratinocytesJournal of Investigative Dermatology, 1996
- Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interactionEuropean Journal of Immunology, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?Immunology Today, 1995
- Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production.Journal of Experimental Medicine, 1995
- The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated ResponseJournal of Investigative Dermatology, 1993
- Epidermal T lymphocytes and HLA-DR expression in psoriasisBritish Journal of Dermatology, 1984
- Interferon in suction blister fluid from psoriatic lesionsBritish Journal of Dermatology, 1983